Global Pharmaceuticals and the University of Cambridge Collaborate to Launch a Laboratory for COVID-19 Testing

 Global Pharmaceuticals and the University of Cambridge Collaborate to Launch a Laboratory for COVID-19 Testing

AstraZeneca and MSD’s Lynparza (Olaparib) Receives the CHMP’s Positive Opinion as 1L Maintenance Treatment for HRD-Positive Advanced Ovarian Cancer

Shots:

  • GSK, AstraZeneca and the University of Cambridge have formed a collaboration, supporting the UK’s government five-pillar plan to boost testing for COVID-19
  • A new testing laboratory will be set up in the University’s Anne McLaren laboratory and will explore the use of alternative chemical reagents for high throughput screening for COVID-19 testing for overcoming the current supply shortages in the UK
  • The joint lab will support UK’s three centralized COVID-19 testing centers by leveraging GSK and AstraZeneca’s expertise in automation, robotics, and optimization to speed up their work and expand capacity

Click here ­to­ read full press release/ article | Ref: GSK  | Image: AstraZeneca

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post